Enhancing suicide prevention outreach via mobile-enabled website design - Slay PD, Castille KW, Hong E, Polizzi N, Hoyt T.
Online outreach campaigns are a potential public health method for reaching service members at risk for suicide. The Real Warriors Campaign website underwent a full redesign in 2019 to enhance its ability to provide crisis resources and increase engagement... (Source: SafetyLit)
Source: SafetyLit - April 23, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Using spatial distance strategically with luxury and popular product displays
(American Marketing Association) The distance between the product and the consumer, whether in real life or in ads, can have a profound influence on how consumers evaluate the product and make purchase decisions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 23, 2021 Category: International Medicine & Public Health Source Type: news

Aggression expression among League of Legends and Fortnite players - a brief report - B álint B, Tényi T, Jeges S, Bernstein LR, Békési B.
BACKGROUND AND AIMS: Our primary goal was to determine and compare the anger expression strategies used by players of the two most popular online games, League of Legends and Fortnite Battle Royale, as well as those used by non-gamers. METHODS: The... (Source: SafetyLit)
Source: SafetyLit - April 22, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Chesterfield senior living community names new executive director
In addition to the Chesterfield job, she will maintain her role as chief revenue officer with the Friendship Villages, which oversees all sales and marketing efforts across the company. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 22, 2021 Category: Pharmaceuticals Authors: Vince Brennan Source Type: news

Apple Executive Says AirTags Designed to Track Items, Not Children or Pets
Following the announcement of AirTags this week, Apple's VP of worldwide iPhone product marketing, Kaiann Drance, and Apple's senior director... (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2021 Category: Consumer Health News Source Type: news

Getinge receives US FDA 510(k) clearance for three products, expanding the Servo ventilator platform
GÖTEBORG, Sweden, April 22, 2021 -- (Healthcare Sales & Marketing Network) -- Today, Getinge announces clearance from the US FDA of several new software options for the Servo-u and Servo-n ventilators. In addition to the latest software upgrades, Get... Devices, FDA Getinge, Servo-u MR ventilator, ventilator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 22, 2021 Category: Pharmaceuticals Source Type: news

Accuray Receives Shonin Approval for ClearRT(TM) Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
Exceptional, Fan-beam Imaging for the Radixact® System Increases Radiation Treatment Options SUNNYVALE, Calif., April 22, 2021 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative Clea... Devices, Oncology, Regulatory Accuray, Radixact System, ClearRT, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 22, 2021 Category: Pharmaceuticals Source Type: news

Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris
All Three Co-Primary Endpoints Were Achieved LAVAL, QC, April 22, 2021 -- (Healthcare Sales & Marketing Network) -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the l... Biopharmaceuticals, Dermatology Bausch Health Companies, Ortho Dermatologics, acne vulgaris (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 22, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participa...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

How to nudge drivers to reduce speed: the case of the left-digit effect - Rubaltelli E, Manicardi D, Orsini F, Mulatti C, Rossi R, Lotto L.
We examined the possible application of the left-digit effect as a nudge to reduce road speed. In the marketing field, this e... (Source: SafetyLit)
Source: SafetyLit - April 21, 2021 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, t... Devices, Interventional, FDA Medtronic, Pipeline Flex Embolization Device, aneurysm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 21, 2021 Category: Pharmaceuticals Source Type: news

Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System(TM)
Patient Enrollment to Begin Within Three Months FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 -- (Healthcare Sales & Marketing Network) -- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced ... Devices, Interventional, Neurosurgery, Regulatory Cerus Endovascular, Contour Neurovascular System, intracranial aneurysm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 21, 2021 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS(TM) Vision System
VERITAS™ Vision System to introduce innovations in fluidics management and usability to fuel surgeons' performance in every cataract procedure, from the easiest to most challenging SANTA ANA, Calif., April 21, 2021 -- (Healthcare Sales & Marketing Netwo... Devices, Ophthalmology, FDA Johnson & Johnson Vision, VERITAS Vision System, phacoemulsification, cataract (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 21, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) ReviewEMA Confirms Overall Benefit-Risk Profile Remains Positive
NEW BRUNSWICK, N.J., April 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of the Company’s COVID-19 vaccine and confirmed the overall benefit-risk profile remains positive. The guidance follows PRAC review of a small number of cases of a very rare adverse event involving blood clots in combination with low platelet counts that can occur within approximately one to three weeks following injection with the Company’s COVID-19 vaccine. As a resul...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

PyrAmes Raises $6 Million in Series A Financing
CUPERTINO, Calif., April 20, 2021 -- (Healthcare Sales & Marketing Network) -- PyrAmes, Inc., a digital healthcare company focused on innovative products for continuous blood pressure monitoring, today announced the completion of a $6 million Series A fin... Devices, Monitoring, Cardiology, Venture Capital PyrAmes, Boppli, blood pressure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Zimmer Biomet Receives FDA Clearance for ROSA(R) Partial Knee System for Robotically-Assisted Partial Knee Arthroplasty
ROSA Partial Knee System Expands Zimmer Biomet's Robotics Portfolio and Adds to the ZBEdge Connected Intelligence Suite WARSAW, Ind., April 20, 2021 -- (Healthcare Sales & Marketing Network) -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global... Devices, Orthopaedic, FDA Zimmer Biomet, ROSA Partial Knee, partial knee replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Company prepares for U.S. IDE clinical trial of its novel metal-free frame designed to reduce complications and preserve long-term treatment options BAAR, Switzerland and MOUNTAIN VIEW, Calif., April 20, 2021 -- (Healthcare Sales & Marketing Network) -... Devices, Interventional, Cardiology atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
SHEFFIELD, England, April 20, 2021 -- (Healthcare Sales & Marketing Network) -- Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from exist... Regenerative Medicine, Venture Capital Rinri Therapeutics, stem cell, sensorineural hearing loss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2021 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Reports 2021 First-Quarter Results
New Brunswick, N.J. (April 20, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2021. “Johnson & Johnson delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices,” said Alex Gorsky, Chairman and Chief Executive Officer. “The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Highmark Health's Bills stadium deal far from the only health plan marketing sponsorship
Sponsorships and naming rights deals are nothing new for both nonprofit and private health plans. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 20, 2021 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Better marketing for a better world
(American Marketing Association) Marketing can be used to benefit the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2021 Category: International Medicine & Public Health Source Type: news

Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); ho...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
LEXINGTON, Mass., April 19, 2021 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, is pleased to announce that the U.S. Food ... Biopharmaceuticals, Oncology, FDA Curis, acute myeloid leukemia, myelodysplastic syndromes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2021 Category: Pharmaceuticals Source Type: news

Nevro Appoints Jon R. Shear as Vice President, Corporate Development
REDWOOD CITY, Calif., April 19, 2021 -- (Healthcare Sales & Marketing Network) -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appoi... Devices, Personnel Nevro Corp, Senza Omnia, Spinal Cord Stimulation, HF10 therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2021 Category: Pharmaceuticals Source Type: news

Haemonetics Provides Update On U.S. Plasma Business
BOSTON, April 19, 2021 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics" or the "Company"), a global medical technology company focused on delivering innovative medical solutions to drive b... Devices Haemonetics, CSL Plasma, NexSys PCS, Plasma Collection System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2021 Category: Pharmaceuticals Source Type: news

Regulatory approval of COVID-19 Vaccine Moderna, MHRA (updated 19th April 2021)
Information for healthcare professionals and the public about the COVID-19 Vaccine Moderna 19 April 2021Added an updated Public Assessment Report following grant of Conditional Marketing Authorisation. 1 April 2021The Information for Healthcare Professionals and Information for UK Recipients documents were replaced with a Summary of Product Characteristics and Patient Information Leaflet, respectively, following grant of Conditional Marketing Authorisation. The Conditions of Authorisation document has been removed and the Public Assessment Report will be updated in due course. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 19, 2021 Category: Consumer Health News Source Type: news

'Things are not what they seem to be': a proposal for the spectrum approach to conspiracy beliefs - Starcevic V, Brakoulias V.
OBJECTIVE: Conspiracy beliefs (also known as conspiracy theories) become more prominent at times of heightened uncertainty and inconsistent or conflicting explanations provided by the authorities for events like terrorist attacks or pandemics, such as COVI... (Source: SafetyLit)
Source: SafetyLit - April 19, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Media constructions of Indigenous women in sexual assault cases: reflections from Australia and Canada - Cripps K.
In 2011, in Australia and Canada, two Aboriginal women - Lynette Daley and Cindy Gladue - died in suspicious circumstances suggestive of sexual homicide. At the time of their deaths, little media attention was given to their cases. However, several years l... (Source: SafetyLit)
Source: SafetyLit - April 19, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

The normalization of violence in commercial kitchens through food media - Meiser ET, Pantumsinchai P.
The Bureau of Labor Statistics estimates that there are 2.53 million cooks and chefs in the United States. Of those, one in four reports experiencing physical violence in the workplace-roughly 632,500 victims. While shocking, this figure fails to account f... (Source: SafetyLit)
Source: SafetyLit - April 19, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Covaxin production to increase 10 times by September: Harsh Vardhan
Highlighting the steps taken to fulfil the requirement of remdesivir, Vardhan in a tweet said, "Production being doubled to 74.1L per month by May; Express permission given to 20 manufacturing plants to increase production; Exports prohibited; Prices capped; Strict monitoring to curb any malpractice, hoarding and black marketing." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2021 Category: Pharmaceuticals Source Type: news

Brief interventions via electronic health record messaging for population-based suicide prevention: mixed methods pilot study - Whiteside U, Richards J, Simon GE.
BACKGROUND: New opportunities to create and evaluate population-based selective prevention programs for suicidal behavior are emerging in health care settings. Standard depression severity measures recorded in electronic medical records (EMRs) can be used ... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

How can psychological science help counter the spread of fake news? - van der Linden S, Roozenbeek J, Maertens R, Basol M, K ácha O, Rathje S, Traberg CS.
In recent years, interest in the psychology of fake news has rapidly increased. We outline the various interventions within psychological science aimed at countering the spread of fake news and misinformation online, focusing primarily on corrective (debun... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Predicting depression level using social media posts - Patidar H, Umre J.
Depression is a major concern snowballing day by day. There can be various causes of depression but mental illness is the main problem. A lot of people suffer from depression and a very few of them go through treatment. One out of six people between ages 1... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Social media activism and convergence in tweet topics after the initial #MeToo movement for two distinct groups of Twitter users - Baik JM, Nyein TH, Modrek S.
Online social media movements are now common and support cultural discussions on difficult health and social topics. The #MeToo movement, focusing on the pervasiveness of sexual assault and harassment, has been one of the largest and most influential onlin... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Twenty-five years of social media: a review of social media applications and definitions from 1994 to 2019 - Aichner T, Gr ünfelder M, Maurer O, Jegeni D.
In this article, the authors present the results from a structured review of the literature, identifying and analyzing the most quoted and dominant definitions of social media (SM) and alternative terms that were used between 1994 and 2019 to identify thei... (Source: SafetyLit)
Source: SafetyLit - April 17, 2021 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
THOUSAND OAKS, Calif., April 16, 2021 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prim... Biopharmaceuticals, Oncology, Mergers & Acquisitions Amgen, Five Prime Therapeutics, immunotherapy, targeted therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2021 Category: Pharmaceuticals Source Type: news

Medivir appoints Magnus Christensen as interim CEO
STOCKHOLM, April 16, 2021 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) announced today that its Board of Directors appoints Magnus Christensen, the company's CFO, as interim CEO of Medivir. Magnus has been CFO of the co... Biopharmaceuticals, Personnel Medivir AB (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2021 Category: Pharmaceuticals Source Type: news

Key policy considerations for reducing public consumption of vice products
(American Marketing Association) Brand asymmetries must be considered when applying cigarette tax hikes and smoke-free restrictions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 16, 2021 Category: International Medicine & Public Health Source Type: news

Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Funding to Support Validation Testing of the First Tankless Inhaled Nitric Oxide (iNO) Wearable Device for Home Use WALTHAM, Mass., April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Third Pole Therapeutics, a privately held company developing... Devices, Venture Capital Third Pole Therapeutics, inhaled nitric oxide, tankless iNO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Shipments have commenced across Canada National sales coverage in full deployment through a dedicated key account managers team Private and public reimbursement activities on target MONTREAL, April 15, 2021 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Product Launch Valeo Pharma, Redesca , Redesca HP, heparin, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Singh to lead Juniper Biologics operations from Singapore and deliver medicines in Oncology, Rare/Orphan Diseases and Gene Therapy SINGAPORE, April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Juniper Biologics, a science-led healthcare compan... Biopharmaceuticals, Personnel Juniper Biologics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes
DUBLIN, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set tha... Devices, Drug Delivery, Product Launch Medtronic, Extended Infusion Set, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors
CE mark enables commercialization of GenPulse™ in EU PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnolog... Devices, Oncology, Regulatory OncoSec Medical, GenPulse, electroporation, gene delivery device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
Drug development leader brings extensive expertise in clinical and overall development strategy and execution across a wide range of therapeutic areas BOSTON, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- HotSpot Therapeutics, Inc, a biot... Biopharmaceuticals, Personnel HotSpot Therapeutics, allosteric medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

GlobalMed Introduces the TotalExam(R) Lite, the Next Generation of Digital General Exam Cameras and Otoscopes for Telemedicine
The TotalExam® Lite Camera Combines State of the Art Imaging in a Lightweight, Economical Package SCOTTSDALE, Ariz., April 14, 2021 -- (Healthcare Sales & Marketing Network) -- GlobalMed, an international provider of virtual health solutions, is pr... Devices, Product Launch GlobalMed, TotalExam Lite, otoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

Ventris Announces Launch of Next Generation Biologic, Allocell(R) AF
NEWPORT BEACH, Calif., April 14, 2021 -- (Healthcare Sales & Marketing Network) -- Ventris Medical, a privately held orthobiologics company focused on design, development and commercialization of allografts and synthetic products for improving patient out... Devices, Orthopaedic, Product Launch Ventris Medical, Allocell AF, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

How nonprofits can drive more giving from their current donor base
This study's data-driven insights can help nonprofits structure their giving options better. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 14, 2021 Category: International Medicine & Public Health Source Type: news

Dr Reddy ’s may mop up $300 million in Sputnik V sales
The company has exclusive marketing and distribution rights for the first 250 million doses of Sputnik V vaccines in the country. This is assuming a base price of around Rs 150 per dose, the price at which the other two vaccines — Serum Institute’s Covishield and Bharat Biotech’s Covaxin — have been procured by government, analysts say. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2021 Category: Pharmaceuticals Source Type: news

To convince the vaccine hesitant, understand their underlying motivations
What will change the minds of those reluctant to get the COVID-19 vaccine? Yale SOM ’s Vineet Kumar and two Yale doctors used the tools of marketing to find out. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 13, 2021 Category: Universities & Medical Training Source Type: news

Woke-a-Cola: How to destroy a world-leading brand in 60 seconds
(Natural News) I’m sure you’ve heard the phrase, “Get Woke, Go Broke.”   In the curious case of Coca-Cola, going woke may be the single biggest branding mistake in the history of marketing. (Article republisshed from TomLuongo.me) In late February a whistleblower came forth with screenshots, posted on YouTube, of slides from Coke’s internal ‘diversity training’... (Source: NaturalNews.com)
Source: NaturalNews.com - April 13, 2021 Category: Consumer Health News Source Type: news